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We describe the application of immunoaffinity extraction and mass spectrometry to the 
analysis of Tyl Gag protein in lysates of Saccharomyces revisiae. A magnetic bead-conjugated 
monoclonal antibody was used to achieve selective xtraction, the specificity of which was 
established by matrix-assisted laser desorption/ionization mass spectrometric (MS) analysis of 
an e~tract of the lysate of cells overexpressing the Tyl Gag protein. MS analysis of similar 
extracts of lysates following tryptic hydrolysis confirmed selective xtraction of the epitope- 
containing peptide fragment. Sufficient sensitivity was achieved to allow the application of this 
approach to the analysis of lysates of wild-type cells. Furthermore, the sequence of the 
epitope-containing peptide was confirmed by electrospray-tandem MS. To our knowledge, 
this constitutes the first report of the application of immunoaffinity extraction and tandem MS 
analysis to the characterization f an antigen recovered from a complex cellular system. 
(J Am Soc Mass Spectrom 1998, 9, 208-215) © 1998 American Society for Mass Spectrometry 
A 
common approach to the characterization f an 
organelle or structure within the cell is to raise 
antibodies against he structure and then deter- 
mine the nature of the antigen recognized by the 
antibodies generated. Initially, for example, information 
on the size of a proteinaceous antigen may be deter- 
mined by western blot analysis. Enzymatic treatment of 
the protein mixture may then be used to determine 
whether the antigen protein shows any post-transla- 
tional modifications, uch as glycosylation or phosphor- 
ylation, and if so whether this alters the antibody 
binding. In order to identify more completely the pro- 
tein with which the structure-specific antibody reacts, 
any antibodies raised may be used to screen appropri- 
ate cDNA expression libraries. This approach as been 
used with considerable success in the identification of 
structural proteins, e.g., cytocentrin in the centrosome 
[1]. However, this antibody screening method for 
cDNA libraries is of limited use where the antibody 
generated recognizes nonlinear or discontinuous 
epitopes or recognizes epitopes after secondary modi- 
fications (as described above), or where the target 
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protein is poorly represented in the cDNA library. An 
alternative approach which circumvents these prob- 
lems, as it does not rely on expression of the antigen, is 
to determine the epitope sequence recognized by the 
antibody. This sequence can then be used to search 
protein sequence databases for identical or homologous 
sequences. Furthermore, the sequence can be used to 
produce an oligonucleotide probe for direct screening 
of genomic or cDNA libraries. 
Several antigen epitope analysis methodologies are 
available. The PEPSCAN technique (Cambridge Re- 
search Biochemicals, Cheshire, UK) uses enzyme-linked 
immunosorbent assays (ELISA) with sets of overlap- 
ping synthetic peptides spanning the known protein 
sequence. This approach as been used successfully for 
many different protein/antibody combinations [2-6] 
including the Tyl structural protein used in this report 
[7]. However, this is an expensive technique and is only 
really cost effectiive for characterizing a series of anti- 
bodies raised against a known protein. A similar ap- 
proach suitable for both known and unknown antigens 
is the screening of peptide libraries. This method relies 
on recognition by the antibody of a linear synthetically 
produced peptide sequence and so is not suitable for 
detection of conformational or post-translationally 
modified epitopes. 
~ 1998 American Society for Mass Spectrometry. Published by Elsevier Science Inc. 
1044-0305/98/$19.00 
PII $1044-0305(97)00250-X 
Received July 22, 1997 
Revised October 20, 1997 
Accepted October 21, 1997 
J Am Soc Mass Spectrom 1998, 9, 208-215 IDENTIFICATION OF PROTEIN ANTIGENS IN CELL LYSATES 209 
An alternative approach to epitope analysis of mono- 
clonal antibodies is used here. This methodology is
based on an immunoaffinity step for isolation of the 
recognized antigen followed by mass spectrometric 
(MS) analysis. Several recent reports have described the 
application of MS to epitope mapping. Suckau et al. [8] 
compared the pattern of proteolytic degradation of a 
free peptide with an antibody-bound, and hence par- 
tially protected, peptide using plasma desorption MS. 
An equivalent approach as been used for an immobi- 
lized antibombesin antibody and its antigen, the gas- 
trin-releasing peptide [9]; in this instance (and in most 
other recent studies in this area) matrix-assisted laser 
desorption/ionization (MALDI) time-of-flight (TOF) 
MS analysis was used. Tomer and co-workers [10] 
recently reported the application of the same proteolytic 
footprinting/MALDI MS strategy for the characteriza- 
tion of the functional epitope on the HIV-1IIIB Gag 
protein. An alternative approach involves initial proteo- 
lytic digestion followed by immunoaffinity extraction 
of epitope-containing fragments. Zhao and Chait [11] 
followed this strategy for the screening of linear 
epitopes in the 26-amino acid peptide, melittin. Macht 
and co-workers [12] have pointed out that immobiliza- 
tion of the antibody may not be necessary for applica- 
tion of either the proteolytic footprinting or prior enzy- 
mic digestion approach when dealing with simple 
systems; in their work, separation of nonepitope pep- 
tides from antibody-bound peptides was achieved by 
ultrafiltration. A recent study by Vouros, Karger and 
coworkers [13] adopts an approach to screening of 
proteolytic fragments using affinity capillary electro- 
phoresis in combination with electrospray MS. 
We describe here the development of an immunoaf- 
finity-based mass spectrometric epitope analysis 
method for use in complex biological systems, uch as 
whole cells, with identification of protein antigens at 
physiologically relevant levels. The reaction of the an- 
tigen and antibody takes place in solution directly from 
the cellular lysate. The system used for development of 
the method is the well-characterized Tyl retrotranspo- 
son present in the yeast Saccharomyces revisiae. The Tyl 
retrotransposon produces a virus-like particle, com- 
posed predominantly of a structural, Gag-like protein, 
during its replication cycle [14]. Many Tyl Gag con- 
structs including both C- and N-terminally truncated 
forms have been found to assemble when overex- 
pressed in yeast cells and have been used as a model 
system for architectural characterization f the Tyl 
virus-like particle [7, 15]. We have used a magnetic 
bead-conjugated monoclonal antibody that binds to a 
known epitope [7] to precipitate specifically the Tyl 
Gag or a fragment from whole and protease-digested 
yeast cell lysates. We have then characterized the affin- 
ity-extracted protein or peptide reacting with the mono- 
clonal antibody by both MALDI-TOF and electrospray 
tandem MS. Furthermore, we have demonstrated the 
sensitivity of the system by successful extraction of the 
antigen from yeast cell lysates containing only the 
wild-type, low levels of Tyl Gag protein. 
Methods 
Yeast Strains 
Strains of Saccharomyces revisiae used were based on 
the host strain MC2 (cir+, leu2-3,112, ura3-5, trpl, 
pep4-3, prcl-407, prb1-1122) as described previously 
[7]. The strain OGS40 was made from transformation f 
MC2 with a 2 u*-based plasmid to overexpress the 
C-terminally truncated Tyl Gag protein, pl-381 (con- 
sisting of the first 381 amino acids of the Tyl Gag 
protein sequence plus an additional fiw~ amino acid 
residues, equence AGSGK, introduced during plasmid 
construction). Cultures were grown in minimal yeast 
media, with galactose induction for the overexpressing 
cell lines [16]. 
Virus-like Particle Preparations 
Purified MA5620 virus-like particles (VLPs) prepared 
from OGS40 yeast cells expressing the C-terminally 
truncated TYA protein, pl-381, were kindly provided 
by British Biotech plc (Oxford, UK). Samples were 
stored in small portions at -80°C. Monomeric pl-381 
protein was prepared for MS analysis by dissociation of
the particles with 0.5 M urea at 20°C. The urea was then 
removed from the solution by dialysis against 10 mM 
ammonium acetate, pH 6.5. The recovery of monomer 
from the Tyl VLPs was estimated to be 50%-80%. 
Preparation of Antibody Beads 
The anti-Tyl monoclonal BB2 [7] was purified by pro- 
tein G affinity chromatography (Pharmacia, Uppsala, 
Sweden). The purified antibody was then coupled to 
magnetic microcellulose beads according to the manu- 
facturer's protocol (Scigen, Sittingbourne, Kent) using 
carbonyldiimidazole. The BB2-cellulose beads were 
then stored at 4°C in TEN-azide buffer (10 mM tris-HC1, 
pH 7.4; 2 mM EDTA; 140 mM NaC1; 0.05% NaN3). 
Preparation of Yeast Cell Lysates 
Yeast cell lysates were prepared for immunoaffinity 
extraction by vortexing cell pellets with glass beads in 
TEN buffer with a cocktail of protease inhibitors. Ly- 
sates were clarified by centrifugation (2000 x g, 5 min) 
before use. The protein concentration f cleared lysates 
was in the range 1.0-1.5 mg mL -1. Lysates were stored 
at -20°C when not analyzed immediate.ly. Trypsin- 
digested lysates were prepared by addition of 33 p,L of 
trypsin (2 mg mL-1 in TEN buffer; Sigma, UK) to 1 mL 
of cell lysate. The mixture was then incubated for 1.5 h 
at 37°C. 
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SDS-PAGE and Western Blot Analysis of Tyl 
VLPs and Cell Lysates 
Samples were electrophoresed on 10% SDS-PAGE gels 
and either visualized by Coomassie blue stain or blotted 
onto nitrocellulose using standard protocols [17, 18]. 
Tyl Gag proteins on nitrocellulose membranes were 
visualized by incubation with the BB2 antibody or 
another anti-Tyl antibody, TYG3 (reacting with the N- 
and C-terminal regions of the Tyl pl-381 protein, 
respectively [7]). Detection was achieved by labeling 
with peroxidaseqabeled rabbit antimouse antibody 
(DAKO, Buckinghamshire, UK) using 4-chloro-l-naph- 
thol (Sigma) as substrate in the presence of H20 2. 
hnmunoaffinity Extraction and Elution 
Tyl Gag proteins were removed from VLP solutions or 
cell lvsates by the addition of 20 IzL (equivalent o 
apprc, ximately 1 mg of beads) of BB2 beads. The mix- 
tures were then incubated at 20°C for 1.5 h with gentle 
heating; the beads were subsequently removed from the 
solution by concentration with a rare earth magnetic bar 
(Scigen). The beads were washed with TEN+0.1% 
Tween-20 (3 × 0.5 mL), followed by water (HPLC 
grade, Rathburn Chemicals, Peeblesshire, Scotland; 5 × 
0.5 mL) before elution of antigen. Samples for analysis 
by electrospray MS were given extra washing steps (3 × 
0.2 mL PBS) before the water washes to remove deter- 
gent which may interfere with the MS analysis. Anti- 
gens specifically bound to the BB2 beads were then 
eluted with an aqueous olution of glycine HCI (5 txL, 
0.1 M, pH 2.3) immediately before MS analysis. After 
elution of bound material, the beads were washed (3 × 
TEN l~uffer) and stored in TEN azide until reuse. 
MALDI-TOF Mass Spectrometry 
Samples were prepared for MS by mixing 2 p~L of the 
BB2 beads eluate with an equal volume of matrix 
solution. Sinapinic acid was used as matrix for the 
analy:sis of the intact Tyl protein samples and c~-cyano- 
4-hydroxycinnamic acid for the trypfic digests; both 
matrices were dissolved in water:acetonitrile (2:1) con- 
taining 0.1'14, trifluoroacetic acid. A portion of the sam- 
ple-matrix mixture (2 /xL) was spotted onto the target 
for analysis. Mass spectra were obtained using a Tof- 
Spec instrument (Micromass UK, Manchester, UK) 
equipped with a 337 nm nitrogen laser. The accelerating 
voltage was 25 kV in linear mode and 23.6 kV in 
reflectron mode; the signal digitization rates were 250 
and 500 MHz, respectively. Data from 50 laser shots 
were averaged for each spectrum using Micromass 
Opus Motif software. External mass calibration in linear 
mode was performed using bovine serum albumin 
samples in sinapinic acid matrix. Calibration in reflec- 
tron mode used a mixture of gramicidin S and bovine 
insulin in c~-cyano-4-hydroxycinnamic cid matrix. 
EIectrospray Mass Spectrometry 
Electrospray mass spectra were obtained using a Micro- 
mass Quattro tandem quadrupole mass spectrometer, 
upgraded to Quattro II specifications. The samples 
eluted from BB2 beads were desalted chromatographi- 
cally by application to a reusable reversed-phase car- 
tridge (1 × 15 ram; Peptide Trap, Michrom BioRe- 
sources, Pleasanton, CA). The cartridge was washed 
with 300/~L aqueous formic acid (0.1%) before recovery 
of the protein or peptide by elution with 80 p,L of 
CH3CN/H20 (80/20) containing 0.1% formic acid. Por- 
tions of the eluate were infused into lhe electrospray 
source at a flow rate of 3/~L/min using a syringe driver 
(Harvard Apparatus, South Natick, MA). For conven- 
tinnal MS analyses, the resolution was set to achieve 
peak widths of -~:1 m/z unit for singly charged ions. For 
tandem MS the resolution of the first quadrupole was 
set to achieve peak widths of singly charged precursor 
ions of "~2 m/z units; the equivalent figure for product 
ion analysis was 1.2-1.8 m/z  units. The mass spectrom- 
eter was repetitively scanned at a rate of 100 m/z 
units/s. Conventional MS data were accumulated for 
1.5 min and tandem MS data for either 8 or 18 min. The 
collision energy used in the tandem MS analyses was 
30-45 eV. Argon was used as collision gas at a recorded 
manifold pressure of 1.3 × 10 -:~ mbar. 
Results 
Mass Spectrometric Analysis of the 7 yl  Structural 
Proteiu from Virus-like Particle,; 
MA5620 virus-like particles purified from yeast cells 
overexpressing file truncated Gag protein pl-381 were 
analyzed by MALDI-TOF MS. These particles are com- 
posed of several hundred copies of the monomeric 
pl-381 protein [15] and so require dissociation before 
analysis. The MALDI-TOF mass spectrum obtained for 
the dissociated MA5620 VLPs (not shown) included a 
prominent signalt at m/z 4;{,224, attributable to the 
singly protonated protein. Doublv and triply charged 
forms were also present, together with an intense signal 
associated with the protonated dimer. The derived 
estimate of molecular mass, 43,223, is within 0.5% of the 
(M+H) + mass of 43,002 calculated from the average 
mass of the amino acid sequence (taking into account 
the additional five amino acid sequence introduced 
during plasmid construction [19]. Figure 1 provides 
further evidence for the identity of the Tyl pl-381 
protein based on SDS-PAGE and western blot analyses 
with two different anti-Tyl monoclonal antibodies. 
(The discrepancy between the molecular weight esti- 
mate based on gel mobilitv and that obtained by 
MALDI MS illustates the common inaccuracy of gel- 
based determinations.) 
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Figure 1. SDS-PAGE and western blot analyses of samples 
prepared for mass spectrometry. Panel A shows a Coomassie 
blue-stained gel with the following components: Lane 1: molecu- 
lar weight markers; lane 2: the purified Tyl protein isolated from 
Tyl virus-like particles and used for mass spectrometric analysis. 
The spot corresponding toTy protein appears between molecular 
weight markers of 45 and 66 kDa. Lanes 3 and 4: }:east cell lysates 
prepared from cells overexpressing the Tyl pl-381 structural 
protein, before (lane 3) and after (lane 4) extraction with antibody 
beads. Panels B and C show western blots prepared using anti- 
bodies recognizing either an N-terminal (panel B) or a C-terminal 
section (panel C) of the Tyl structural protein. Lane 1: purified Tyl 
protein (as panel A, lane 2); lane 2: extract of yeast cell lysate; lane 
3: yeast cell lysate (as panel A, lane 3). 
Optimization of Immunoaffinity 
Extraction Procedures 
The extraction procedure developed for cell lysate in- 
cubations with antibody beads (for subsequent MS 
analysis) was based on conditions used for similar 
immunoaffinity procedures uch as western blotting 
and ELISAs. The following parameters were evaluated 
for optimization of extraction and MS: (a) conditions for 
the washing of the antibody beads after initial extrac- 
tion of lysates, (b) choice of elution agent for recovery of 
bound protein, and (c) the matrix used for MALDI-TOF 
MS. The removal of detergent used during initial wash- 
ing of the antibody-beads/antigen complex (as de- 
scribed in the Methods section) was found to be partic- 
ularly important in order to avoid interfering signals 
during MS analysis. Aqueous glycine hydrochloride 
achieved efficient dissociation of the antigen from the 
antibody bead-antigen complex and did not interfere 
with the subsequent MS analysis [9]. Aqueous trifluoro- 
acetic acid (1%) was also effective for dissociation of the 
complex but was less useful in the subsequent 
MALDI-MS analysis because matrix crystal formation 
was impaired, presumably by material co-extracted 
from the antibody-coupled beads. 
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Figure 2. MALDI-TOF mass spectrum of Tyl structural protein 
isolated from a lysate of ),east cells (strain OGS40) overexpressing 
the Tyl pl-381 structural protein. 
Analysis of Tyl Protein Extracted frorn Yeast Cell 
Lysates 
Lysates were prepared from cells (OGS40 strain) over- 
expressing the Tyl pl-381 protein and then incubated 
with magnetic beads coupled to the anti-Tyl monoclo- 
hal antibody BB2. The MALDI-TOF mass spectrum of 
the protein sample eluted from the BB2 beads is shown 
in Figure 2. The major peak present at m/z 42,969 
shows good agreement with the calculated molecular 
mass of 43,002 for the Tyl p1-381 construct. A peak at 
m/z 21,446 is attributed to the doubly protonated form. 
The BB2 beads are therefore successfully extracting 
from the complex yeast cell lysate a single protein with 
a spectrum equivalent to that obtained from the disso- 
ciated Tyl virus-like particle preparations. The identity 
of the eluted protein as Tyl pl-381 protein was sup- 
ported by western blot analysis using both a C-termi- 
nal-reacting and an N-terminal-reacting anti-Tyl anti- 
body (Figure 1B,C). No other protein spots were 
revealed by western blotting with either antibody. 
Figure 1 also shows the results of Coomassie-blue 
staining of SDS-PAGE separations of the OGS40 cell 
lysate before and after extraction with the antibody 
beads. In neither case is a discrete spot observed corre- 
sponding to the Tyl protein and the gross protein 
composition is not altered by extraction with the anti- 
body beads. (Compare lanes 3 and 4 in Figure 1A.) 
Determinations of the concentration of the Tyl protein 
in the cell lysates are necessarily very approximate; 
based on western blotting and densitometry, however, 
it is estimated that Tyl represents a maximum of 2% of 
total protein in the overexpressing yeast strain. Thus, 1 
mL of lysate, corresponding to1--1.5 mg total protein, is 
expected to contain 0.5-0.7 nmo} of Tyl protein. West- 
ern blotting (not shown) of a cell lysate after extraction 
with antibody beads revealed that extraction of the Tyl 
protein was incomplete so an estimate of 0.5-0.7 nmol 
Tyl in an extract of 1 mL of lysate represents an upper 
limit. 
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Figure 3. MALDI-TOF mass spectra of samples recovered by 
immunoaffinity extraction of yeast cell lysates, after proteolytic 
digestion with trypsin. A: Spectrum of the extract of 1 mL of 
digested lysate of the cells overexpressing Tyl pl-381 protein. T2 
denotes the second expected tryptic fragment. B: Spectrum of the 
extract of a mixture comprising 0.1 mL tryptic lysate from the cells 
overexpressing the Tyl pl-381 protein together with 0.9 mL 
undigested, normal yeast cell lysate. C: Spectrum of the extract of 
I mL of digested lysate of cells expressing Tyl protein at wild-type 
levels. 
Extraction and Analysis of Protein Fragments 
from Trypsin-digested Cell Lysates 
An enzymatic digest was made of the whole cell lysate 
before extraction with the antibody beads. Figure 3A 
shows the mass spectrum of the sample recovered by 
immunoaffinity extraction of a tryptic digest of a lysate 
from yeast cells (OGS40) overexpressing the Tyl pl-381 
protein. The spectrum shows a single peak at m/z 
1640.4 which is consistent with a singly protonated ion 
deriw_~d from the predicted tryptic fragment (T2) of Tyl 
pl-381. Analyses of replicate (n = 4) cell lysates on 
separate occasions indicated a satisfactory eproducibil- 
ity of determination f the peptide mass: 1639.7 _+ 1.1 
Da (mean + S.D.). This fragment incorporates residues 
25-39 (EVHTNQDPLDVSASK) and thus encompasses 
the known epitope of the BB2 antibody at residues 
27-32, as determined by PEPSCAN analysis [7]. 
The sensitivity of the immunoaffinity extraction and 
mass spectrometric analysis procedure was tested by 
dilution of the trypsin-digested lysate of overexpressing 
cells (OGS40 strain) with lysate from the nonoverex- 
pressing host yeast strain, MC2. Figure 3B shows the 
analysis of a sample xtracted from a mixture of 0.9 mL 
of MC2 lysate and 0.1 mL of the digested OGS40 lysate 
(compared with 1 mL of OGS40 lysate used to obtain 
the data shown in Figure 3A). 
It is apparent from Figure 3B that the trypsin present 
in the OGS40 lysate reaction mixture has partially 
digested the Tyl protein present at wild-type levels in 
the MC2 yeast lysate. The spectrum shows major peaks 
for the T(2+3) tryptic fragment (residues 25-45) at m/z 
2360.1 (calculated value 2360.5) and the limit digest 
fragment T2 at m/z 1640.3. A minor signal corresponds 
to the T(2+3+4) tryptic fragment (residues 25-49) at 
m/z 2747.4 (calculated value 2748.0). The partially 
digested forms were subject o complete digestion by 
increasing the incubation time after addition of the 
wild-type lysate or by adding further trypsin; subse- 
quent MALDI-TOF MS analyses gave spectra identical 
to that shown in Figure 3A. 
Extraction of Wild-type Yeast Cell Lysates 
The dilution experiments described above suggested 
that the immunoaffinity extraction-MALDI MS tech- 
nique was sufficiently sensitive to allow characteriza- 
tion of the Tyl epitope at wild-type levels. Tryptic 
digests of nonoverexpressing MC2 lysates were there- 
fore analyzed for confirmation ofthe system sensitivity. 
The reproducibility and robustness of the procedure 
were also established by analyzing several isolates, by 
extracting portions of the same isolate after varying 
times of storage and by assessing the utility of antibody 
beads for multiple re-use. 
Figure 3C shows the MALDI-TOF mass spectrum of 
the immunoaffinity extract of a digest of an MC2 lysate. 
(As with the analyses of the OGS40 strain, 1 mL of 
lysate was used, corresponding toan approximate c ll 
number of 5 × 108 and an amount of protein of 1.0-1.5 
mg; a 20% portion of the extract was used for MS 
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analysis.) The spectrum shows a single peak of m/z 
1640.3. The concentration of Tyl protein in the wild- 
type MC2 lysate is estimated by western blotting and 
ELISA assay to be at least an order of magnitude lower 
than in the overexpressing OGS40 strain. 
Identical MALDI-TOF mass spectra showing single 
components were obtained from analyses of several cell 
lysates. Analyses of aliquots of the same cell lysate on 
four separate days confirmed the reproducibility of 
determination of the mass of the extracted peptide: 
1638.4 + 0.4 Da (mean +_ S.D.). The beads were found to 
be reusable after elution of antigens with consistent 
data observed for at least five consecutive uses. The 
volume of lysate extracted could be reduced to 0.5 mL 
without significant loss in signal quality (data not 
shown). 
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Electrospray Analysis 
The further development of the affinity extraction-MS 
approach described above relies on the sequence deter- 
mination of tryptic or other fragments eluted from 
antibody beads. The searching of protein databases for 
location of the protein epitope recognized by mass 
spectrometric analysis will be greatly facilitated if mo- 
lecular weight information is supplemented by partial 
or total sequence data [20, 21]. Supplementary experi- 
ments were therefore performed to establish whether 
the sample preparation techniques described above 
were compatible also with electrospray tandem MS 
analysis to provide sequence data. 
The mass spectrum obtained by conventional elec- 
trospray MS analysis of an immunoaffinity extract of 
the tryptic hydrolysate of a wild-type cell lysate (not 
shown) clearly indicated the compatibility of the extrac- 
tion procedure with electrospray. Two prominent ions 
were observed, attributable to [M+2H] 2~ and 
[M+3H] 3+ ions derived from a single peptide. Analyses 
of replicate xtracts of a wild-type cell lysate yielded a 
peptide mass of 1638.9 + 0.3 Da (mean -+ S.D.; n = 9), 
in good agreement with the estimates of molecular 
mass from MALDI MS analysis. 
The prominence of the triply protonated ion in the 
conventional ESI spectrum of a tryptic peptide is con- 
sistent with the presence of a histidine, providing a 
third basic site in addition to the N-terminal amine and 
the side chain of the C-terminal residue (lysine or 
arginine). The sequence of the extracted peptide was 
established by ESI-tandem MS using both [M+2H] 2. 
and [M+3H] 3. as precursor ions. The respective prod- 
uct ion spectra are shown in Figure 4A and 4B; the 
assignments ofproduct ions are shown in Figure 5. (The 
nomenclature used is the Biemann variant [22] of the 
original Roepstorff and Fohlman proposal [23].) Both 
spectra include ions of m/z 147 attributable to the y~ 
ion from C-terminal lysine (and lack a significant ion of 
m/z 175 which would indicate C-terminal arginine), 
providing a suitable starting point for facile interpreta- 
tion of the spectra, y-Series ions associated with cleav- 
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Figure 4. Tandem MS analyses of the extract of 1 mL of digested 
lysate of cells expressing Tyl protein at wild-type levels. A: 
Product ion spectrum of the [M+2H] :~- ions derived from the T2 
tryptic fragment. B: Product ion spectrum of the [M + 3H] 3. ions 
derived from the T2 tryptic fragment. 
age of 12 of the 14 peptide bonds are observed in one or 
both of the product ion spectra. 
Discuss ion  
Antibodies against known antigens have long been 
used for the recovery prior to MS analysis of antigens 
such as steroids in blood plasma [24, 25] and eico- 
sanoids in urine [26, 27]. The development of the 
electrospray and MALDI methods have made the im- 
munoaffinity extraction/MS combination attractive for 
the selective analysis of more polar and higher molec- 
ular weight compounds. Initial applications of this 
approach to the analysis of peptides and proteins 
present in solutions of simple mixtures [8, 9, 11, 28-30] 
have been extended recently to the analysis of more 
complex biological systems [31-37]. In the present 
work, extraction of yeast cell lysates (and tryptic digests 
thereof) with a monoclonal antibody coupled to mag- 
netic beads has been shown to provide samples uitable 
for analysis by both MALDI and electrospray MS. The 
test system used for the development of these combined 
immunoaffinity extraction/MS methodologies, the Gag 
protein of the Tyl retrotransposon, has involved a 
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Figure 5. Product ions from CAD of [M+2H] 2÷ ions (A) and 
[M+3H] 3. ions (B) derived from the T2 tryptic fragment, ob- 
served uring electrospray tandem MS analysis of the extract of 1 
mL of c, igested lysate of cells expressing Tyl protein at wild-type 
levels (]~igure 4). 
well-characterized antigen-antibody combination. The 
methods described are quite rapid and, owing to the 
instrumental sensitivity, extremely sparing in terms of 
the biological material required. Samples prepared 
from extraction of lysates equivalent to 108 yeast cells 
were sufficient for five separate MALDI-MS analyses or 
a single electrospray tandem MS analysis. As empha- 
sized above, determination of the proportion of total 
protein accounted for by the Tyl Gag protein is neces- 
sarily very approximate; crude estimates uggest a 
figure of less than 2% in the overexpressing cells and 
substantially ess in wild-type yeast. This suggests that 
further development ofthese procedures using antibod- 
ies raised against, for example, structural components 
within the cell need not be restricted to the most 
prevalent proteins. The avidity of the antibody for its 
substrate will, of course, limit the ultimate sensitivity of 
the assay for any individual antigen. Available evidence 
(based on gel mobilities before and after subjection to 
reducing conditions) suggests that the native structure 
of the Tyl Gag protein does not incorporate disulfide 
bonds Further evaluation is required to establish the 
applicability of the methods described here to the 
analysis of proteins amenable to proteolytic digestion 
only after reduction and alkylation. 
The use of magnetic beads, rather than the Sepharose 
beads often used for other immunoaffinity extraction 
protocols, was particularly advantageous for extraction 
of the yeast cell lysates. The magnetic beads, together 
with the antigen-antibody complex, were concentrated 
using a magnetic bar, thus avoiding the contamination 
of the recovered solid phase by cellular debris that may 
result from centrifugation. Furthermore, the use of 
magnetic beads places fewer constraints on the sample 
volumes used for extraction or washing. The selectivity 
of reco~ery of targeted cellular components will depend 
upon the specificity of the antibody used for extraction, 
as is ailways the case with immunoaffinity-based meth- 
odologies, such as western blotting, ELISA, immuno- 
precipitation, and library screening with antibodies. 
With the present technique, however, a very high 
specificity of characterization is achieved by the MS and 
tandem MS analyses of the extract. 
The use of tryptic fragment masses for the recogni- 
tion of proteins on the basis of mass spectrometric data 
and database searching was introduced several years 
ago [38-42] and has been recently reviewed [43]. A 
number of refinements to the search routine may be 
incorporated, including the specification of full or par- 
tial sequence data for selected proteolytic peptides [20, 
21]. The present work has demonstrated the facility 
with which extensive sequence data may be obtained by 
tandem MS analysis of an epitope-containing fragment 
recovered by immunoaffinity extraction. When the ob- 
jective of the immunoaffinity extraction/MS analysis is 
identification of file cellular protein recognized by the 
antibody, rather than the sequencing of the epitope, the 
intact protein may be recovered (as demonstrated here) 
prior to proteolysis, MS characterization of the frag- 
ments, and database searching. Such an approach as 
recently been described by McCormack et al. [37]. As a 
complement to this strategy, contiguous amino acid 
sequences can be used to prepare oligonucleotide 
probes for polymerase chain reaction (PCR) amplifica- 
tion of the sequence from genomic DNA or mRNA. 
Fragments generated can then be used for library 
screening using DNA hybridization or PCR ap- 
proaches. Thus, even if the antibody recognizes a com- 
pletely novel antigen, the sequence of which is not 
available on any database, tools can be made which 
make isolation and subsequent identification of the 
antigen possible. 
This report has focused on the development of 
immunoaffinity extraction and MS for the confirmation 
of a linear cellular epitope incorporating no post-trans- 
lational modifications. The use of MS for the analysis of 
extracted proteins and of proteolytic fragments incor- 
porating the epitope sequence should mean that the 
characterization of post-translationally modified 
epitopes can be achieved using the same approach. The 
applicability of these techniques to the determination f 
cellular components incorporating conformational (dis- 
continuous) epitopes remains to be established. Proteo- 
lytic digestion of the antibody-bound protein antigen 
(that is, after immunoaffinity extraction of the cell 
lysate) may achieve this objective [10] but further work 
is required. 
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